CADILA PHARMS LTD FDA Approval ANDA 210021

ANDA 210021

CADILA PHARMS LTD

FDA Drug Application

Application #210021

Application Sponsors

ANDA 210021CADILA PHARMS LTD

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001CAPSULE;ORALEQ 2MG BASE0TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDE
002CAPSULE;ORALEQ 4MG BASE0TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDE
003CAPSULE;ORALEQ 6MG BASE0TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2019-03-26STANDARD
LABELING; LabelingSUPPL2AP2022-05-25STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null15

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

CADILA PHARMS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210021
            [companyName] => CADILA PHARMS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"TIZANIDINE HYDROCHLORIDE","activeIngredients":"TIZANIDINE HYDROCHLORIDE","strength":"EQ 2MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"TIZANIDINE HYDROCHLORIDE","activeIngredients":"TIZANIDINE HYDROCHLORIDE","strength":"EQ 4MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"TIZANIDINE HYDROCHLORIDE","activeIngredients":"TIZANIDINE HYDROCHLORIDE","strength":"EQ 6MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/26\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-03-26
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.